North Rock Partners, LLC Abbott Laboratories Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, North Rock Partners, LLC holds 17,284 shares of ABT stock, worth $2.06 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

17,284

Previous 19,175 9.86%

Holding current value

$2.06 Million

Previous $1.99 Million 1.1%

% of portfolio

0.17%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $189,232 - $223,383	-1,891 Reduced 9.86%	17,284 $1.97 Million
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $137,697 - $153,705	-1,367 Reduced 6.65%	19,175 $1.99 Million
Q1 2024 May 07, 2024	BUY	$109.52 - $120.96 $245,215 - $270,829	2,239 Added 12.23%	20,542 $2.33 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $236,207 - $289,137	2,619 Added 16.7%	18,303 $2.01 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $50,821 - $60,977	532 Added 3.51%	15,684 $1.52 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $141,797 - $157,992	1,407 Added 10.24%	15,152 $1.65 Million
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $256,775 - $302,240	-2,651 Reduced 16.17%	13,745 $1.39 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $1.19 Million - $1.39 Million	-12,489 Reduced 43.24%	16,396 $1.8 Million
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $58,152 - $67,330	601 Added 2.12%	28,885 $2.8 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $52,872 - $63,905	-518 Reduced 1.8%	28,284 $3.07 Million
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $17,673 - $21,551	-155 Reduced 0.54%	28,802 $3.41 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $269,993 - $330,592	2,337 Added 8.78%	28,957 $4.08 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $191,905 - $212,303	1,645 Added 6.59%	26,620 $3.22 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $304,886 - $358,895	2,882 Added 13.04%	24,975 $2.9 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $4,462 - $5,257	41 Added 0.19%	22,093 $2.65 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $131,670 - $143,482	-1,254 Reduced 5.38%	22,052 $2.41 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $2.14 Million - $2.59 Million	23,306 New	23,306 $2.54 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $4.19 Million - $5.36 Million	-54,722 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $2.71 Million - $3.96 Million	43,152 Added 372.96%	54,722 $4.32 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $2.04 Million - $2.27 Million	-25,970 Reduced 69.18%	11,570 $1.01 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $1.93 Million - $2.15 Million	24,609 Added 190.31%	37,540 $1.01 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $1.06 Million - $1.15 Million	12,931 New	12,931 $1.08 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $2.31 Million - $2.8 Million	-34,930 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $2.29 Million - $2.59 Million	34,930 New	34,930 $2.53 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Abbott Laboratories Transaction History